Investigational cytokine-targeted therapies for ulcerative colitis

Author： Monteleone Giovanni  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.22, Iss.9, 2013-09, pp. : 1123-1132

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparative Tolerability of Therapies for Ulcerative Colitis

By Ardizzone S.   Porro G.B.  

Drug Safety, Vol. 25, Iss. 8, 2002-01 ,pp. : 561-582

Adis International

Access to resources Recommend Favorite

Novel therapies in the treatment of ulcerative colitis

By Tuvlin Jeffrey A   Kane Sunanda V  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 3, 2003-03 ,pp. : 483-490

Informa Healthcare

Access to resources Recommend Favorite

Novel therapies in the treatment of ulcerative colitis

By Kane Sunanda V  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 7, 2001-07 ,pp. : 1223-1229

Informa Healthcare

Access to resources Recommend Favorite

Investigational therapies targeted to the treatment of benign prostatic hyperplasia

By Gravas Stavros   de la Rosette Jean JMCH  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 3, 2013-03 ,pp. : 357-368

Informa Healthcare

Access to resources Recommend Favorite

Biologic therapies in ulcerative colitis: primi inter pares?

By  

Current Drug Targets, Vol. 19, Iss. 7, 2018-04 ,pp. : 748-756

Bentham Science Publishers

Access to resources Recommend Favorite